Standout Papers

Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin Improves Cardiac Function in Non-Diabetic Ra... 2019 2026 2021 2023 242
  1. Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin Improves Cardiac Function in Non-Diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction (2019)
    Salva R. Yurista, Herman H.W. Silljé et al. European Journal of Heart Failure

Immediate Impact

60 standout
Sub-graph 1 of 24

Citing Papers

Mitochondrial dysfunction: mechanisms and advances in therapy
2024 Standout
Mitochondria-targeted BODIPY dyes for small molecule recognition, bio-imaging and photodynamic therapy
2024 Standout
1 intermediate paper

Works of Mario Pávez being referenced

Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?
2022
Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin Improves Cardiac Function in Non-Diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction
2019 Standout

Author Peers

Author Last Decade Papers Cites
Mario Pávez 265 250 248 18 616
L. Amato 123 206 176 16 552
Francisco R. González‐Pacheco 280 149 231 16 697
Chenguang Li 250 344 197 20 710
Nozomi Fukai 175 177 121 18 569
Christian Negut 173 226 368 16 724
Anna Wickman 227 275 347 26 717
Jiandong Zhang 129 190 154 22 631
Jin Feng 180 181 167 20 597
Dajun Wang 270 106 384 16 692
Megumi Inuzuka 256 157 211 14 680

All Works

Loading papers...

Rankless by CCL
2026